Literature DB >> 29478866

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Andrea K Viecelli1, Allison Tong2, Emma O'Lone2, Angela Ju2, Camilla S Hanson2, Benedicte Sautenet3, Jonathan C Craig2, Braden Manns4, Martin Howell2, Eric Chemla5, Lai-Seong Hooi6, David W Johnson7, Timmy Lee8, Charmaine E Lok9, Kevan R Polkinghorne10, Robert R Quinn11, Tushar Vachharajani12, Raymond Vanholder13, Li Zuo14, Carmel M Hawley7.   

Abstract

Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but frequently are neither patient relevant nor measured consistently in randomized trials. A Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) consensus workshop was convened to discuss the development of a core outcome measure for vascular access. 13 patients/caregivers and 46 professionals (clinicians, policy makers, industry representatives, and researchers) attended. Participants advocated for vascular access function to be a core outcome based on the broad applicability of function regardless of access type, involvement of a multidisciplinary team in achieving a functioning access, and the impact of access function on quality of life, survival, and other access-related outcomes. A core outcome measure for vascular access required demonstrable feasibility for implementation across different clinical and trial settings. Participants advocated for a practical and flexible outcome measure with a simple actionable definition. Integrating patients' values and preferences was warranted to enhance the relevance of the measure. Proposed outcome measures for function included "uninterrupted use of the access without the need for interventions" and "ability to receive prescribed dialysis," but not "access blood flow," which was deemed too expensive and unreliable. These recommendations will inform the definition and implementation of a core outcome measure for vascular access function in hemodialysis trials.
Copyright © 2018 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Keywords:  Clinical research; Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD); consensus; hemodialysis; nephrology research; outcome; outcome measure; patient-centered care; shared decision making; vascular access

Mesh:

Year:  2018        PMID: 29478866     DOI: 10.1053/j.ajkd.2017.12.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  Fistula Interventions: Less Is More.

Authors:  Charmaine E Lok
Journal:  J Am Soc Nephrol       Date:  2019-10-14       Impact factor: 10.121

Review 2.  Single needle hemodialysis: is the past the future?

Authors:  Raymond Vanholder
Journal:  J Nephrol       Date:  2019-09-19       Impact factor: 3.902

3.  Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Authors:  Allison Tong; Braden Manns; Angela Yee Moon Wang; Brenda Hemmelgarn; David C Wheeler; John Gill; Peter Tugwell; Robert Pecoits-Filho; Sally Crowe; Tess Harris; Wim Van Biesen; Wolfgang C Winkelmayer; Adeera Levin; Aliza Thompson; Vlado Perkovic; Angela Ju; Talia Gutman; Amelie Bernier-Jean; Andrea K Viecelli; Emma O'Lone; Jenny Shen; Michelle A Josephson; Yeoungjee Cho; David W Johnson; Bénédicte Sautenet; Marcello Tonelli; Jonathan C Craig
Journal:  Kidney Int       Date:  2018-10-22       Impact factor: 10.612

4.  Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Authors:  Allison Tong; Sally Crowe; John S Gill; Tess Harris; Brenda R Hemmelgarn; Braden Manns; Roberto Pecoits-Filho; Peter Tugwell; Wim van Biesen; Angela Yee Moon Wang; David C Wheeler; Wolfgang C Winkelmayer; Talia Gutman; Angela Ju; Emma O'Lone; Benedicte Sautenet; Andrea Viecelli; Jonathan C Craig
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

5.  Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Authors:  Andrea K Viecelli; Kevan R Polkinghorne; Elaine M Pascoe; Peta-Anne Paul-Brent; Carmel M Hawley; Sunil V Badve; Alan Cass; Lai-Seong Hooi; Peter G Kerr; Trevor A Mori; Loke-Meng Ong; David Voss; David W Johnson; Ashley B Irish
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

6.  Clinical outcomes following the surgery of new autologous arteriovenous fistulas proximal to the failed ones in end-stage renal disease patients: a retrospective cohort study.

Authors:  Xianglei Kong; Lijun Tang; Liming Liang; Wei Cao; Lei Zhang; Wei Yong; Nannan Ding; Wenbin Li; Zunsong Wang; Dongmei Xu
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

7.  Vascular access-specific health-related quality of life impacts among hemodialysis patients: qualitative development of the hemodialysis access-related quality of life (HARQ) instrument.

Authors:  Robert J Nordyke; Gina Nicholson; Shawn M Gage; Ted Lithgow; Jonathan Himmelfarb; Matthew B Rivara; Ron D Hays; Karen Woo; John Devin Peipert
Journal:  BMC Nephrol       Date:  2020-01-14       Impact factor: 2.388

Review 8.  Shared decision-making in hemodialysis vascular access practice.

Authors:  Mariana Murea; Carl R Grey; Charmaine E Lok
Journal:  Kidney Int       Date:  2021-07-08       Impact factor: 18.998

9.  Shared decision-making in advanced kidney disease: a scoping review protocol.

Authors:  Noel Engels; Gretchen de Graav; Paul van der Nat; Marinus van den Dorpel; Willem Jan Bos; Anne M Stiggelbout
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692

10.  Practice patterns of dialysis access and outcomes in patients wait-listed early for kidney transplantation.

Authors:  Raphaëlle Sylvestre; Natalia Alencar de Pinho; Ziad A Massy; Christian Jacquelinet; Mathilde Prezelin-Reydit; Roula Galland; Bénédicte Stengel; Raphael Coscas
Journal:  BMC Nephrol       Date:  2020-10-02       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.